Evidence map›Paper›PMID 22738169›Full record

ArticleBMC bioinformatics2012

Towards a theoretical understanding of false positives in DNA motif finding.

Amin Zia, Alan M Moses

Abstract read
In one paragraph

Article in BMC bioinformatics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Amin ZiaDepartment of Cell & Systems Biology, University of Toronto, Toronto, ON, Canada.
Alan M Moses

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDetection of false-positive motifs is one of the main causes of low performance in de novo DNA motif-finding methods. Despite the substantial algorithm development effort in this area, recent comprehensive benchmark studies revealed that the performance of DNA motif-finders leaves room for improvement in realistic scenarios.

resultsUsing large-deviations theory, we derive a remarkably simple relationship that describes the dependence of false positives on dataset size for the one-occurrence per sequence motif-finding problem. As expected, we predict that false-positives can be reduced by decreasing the sequence length or by adding more sequences to the dataset. Interestingly, we find that the false-positive strength depends more strongly on the number of sequences in the dataset than it does on the sequence length, but that the dependence on the number of sequences diminishes, after which adding more sequences does not reduce the false-positive rate significantly. We compare our theoretical predictions by applying four popular motif-finding algorithms that solve the one-occurrence-per-sequence problem (MEME, the Gibbs Sampler, Weeder, and GIMSAN) to simulated data that contain no motifs. We find that the dependence of false positives detected by these softwares on the motif-finding parameters is similar to that predicted by our formula.

conclusionsWe quantify the relationship between the sequence search space and motif-finding false-positives. Based on the simple formula we derive, we provide a number of intuitive rules of thumb that may be used to enhance motif-finding results in practice. Our results provide a theoretical advance in an important problem in computational biology.

Indexed as

AlgorithmsNucleotide MotifsBase SequenceComputational BiologyComputer SimulationSequence Analysis, DNASoftware

Identifiers

PMID22738169
PMCPMC3436861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.